Evidence map›Paper›PMID 39351175›Full record

ArticleWorld journal of gastrointestinal endoscopy2024

How secure can we expect the surveillance policies to be after the implementation in T1 polyps with carcinoma?

Cristina Mateos Sanchez, Elvira Quintanilla Lazaro, Luis Ramon Rabago

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cristina Mateos SanchezDepartment of Gastroenterological, Severo Ochoa Hospital, Madrid, Leganes 28911, Spain.
Elvira Quintanilla LazaroDepartment of Gastroenterological, Severo Ochoa Hospital, Madrid, Leganes 28911, Spain.
Luis Ramon RabagoDepartment of Gastroenterology, San Rafael Hospital, Madrid 28016, Spain. lrabagot@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 7% of the polyps resected endoscopically have an adenocarcinoma focus, with no previous endoscopic evidence of malignancy. This raises the question of whether endoscopic resection has been curative. Furthermore, there is no consensus on what the endoscopic and histological criteria for good prognosis are, the appropriate follow-up strategy and what are the long-term results. The aim of the retrospective study by Fábián

Indexed as

Endoscopic and histologic poor prognostic criteriaHistological recurrence rate of pT1 adenocarcinomapT1 adenocarcinoma polypspT1 follow up management

Identifiers

PMID39351175
PMCPMC11438583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.